CLINICAL_TRIALS
trial_result
· 2015-02-25
Clinical Trial Update: AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer [Phase 3]
Summary
Phase 3 trial of Avastin added to chemotherapy for platinum-resistant ovarian cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-02-25